Andera Life Sciences closes sixth fund above target on EUR 456m
Andera Partners' life sciences arm has closed its sixth life science venture capital fund, BioDiscovery 6, on EUR 456m as LPs increasingly shift capital towards more focused strategies.
More on Venture
Revo Capital preps third fund for 2023 launch
VC firm aims to raise USD 75m-150m from private and public investors including blue-chip institutional LPs in Europe, MENA and US
Getir plans new funding round for H1 2023
Fast grocery delivery group could fetch a valuation above the USD 10bn-plus of its last round
Women in VC: Revaia’s Albizzati on founding a female-led firm and navigating valuations in 2023
Co-founder Alice Albizzati outlines the growth equity firm's priorities as it heads for the final close of its EUR 500m Fund II
InnovaFonds gears up for first close of new SME fund
French GP’s mezzanine and small equity tickets vehicle aims to attract institutional investors and has a EUR 100m target
Latest News
McDermott adds to German PE team with Noerr and Latham duo
Noerr’s Holger Ebersberger and Latham & Watkins’ Hanno Witt to join the firm’s Munich office
MML launches lower-mid-market strategy for UK, Northern European B2B assets
London-headquartered GP invested in AI provider MIcompany in first deal for new strategy this week
Revo Capital preps third fund for 2023 launch
VC firm aims to raise USD 75m-150m from private and public investors including blue-chip institutional LPs in Europe, MENA and US
Oakley raises EUR 2.85bn for fifth flagship fund
More than twice the size of its 2019 predecessor, the vehicle will allow for larger equity tickets, more investments and bolt-ons